Parker-Hannifin Corporation
Shortcut
8.37Normalized diluted EPS
+2.4% vs Street
Street
8.17Normalized diluted EPS
November 1 consensus snapshot
Real
8.90Reported normalized EPS
Model download
Explore the assumptions and calculations behind the forecast. This is the agent’s original workbook. Its review didn’t finish, so it hasn’t been checked or repaired.
Shortcut’s reasoning.
Q1 FY27 guide (6-Aug-26): adjusted EPS ~$8.07, ~9% reported / ~8% organic sales growth, 27.7% adj. segment margin, excluding Filtration Group (FGC). Frozen consensus $8.17 sits only ~$0.10 above guide - the same set-up as each of the last 4 quarters, when Parker beat its own guide by $0.42-1.11.
Filtration Group closed 13-Aug-26: ~$274m of sales in the quarter (pro-rata of the ~$1.8bn 10.5-month contribution), ~60/40 NA/International; issuer says neutral to Q1 adjusted EPS - modelled FGC segment income (~$59m) roughly offsets ~$57m of incremental interest.
Organic growth 8.5% (NA 8.0%, Intl 7.5%, Aero 10.5%) vs ~8% guide: rolling-12 orders +12% and record $12.8bn backlog at Jun-26, ISM PMI 54.5 in Sep-26, Dover +7.1% organic, GE Aerospace revenue +18% and Howmet commercial aero +32% in the Sep-26 quarter (Honeywell Aerospace +2% is the negative read-across).
Legacy adjusted segment margin ~28.1% vs 27.7% guide (Parker beat its quarterly margin guide in 3 of the last 4 quarters); corporate G&A $50m, adjusted other expense $55m (Q1 seasonally high), interest $142m, 22.5% tax, 127.7m diluted shares -> $8.37 adjusted EPS (+2.5% vs consensus), not inflated by beat rate.
GAAP EPS $6.79 is below the $7.10 guide because FGC amortization (~$36m), FGC integration/step-up and transaction costs (~$65m) are new adjustments not in guidance.
On the record.
- Reporting period
- FQ1 2027 (quarter ended 2026-09-30)
- Reporting basis
- Adjusted (non-GAAP) diluted EPS per common share, USD = normalized EPS basis
- Consensus snapshot
- November 1, 2026
- Model / effort
- Opus 5.5 · High effort
- Workbook
- Original workbook · review incomplete
Record history
- Forecast generated
- Nov 1, 2026 at 10:52 PM PST
- First posted
- Nov 2, 2026 at 4:10 PM PST
- Result checked
- Nov 6, 2026 at 1:55 AM PST
Result basis
Provider normalized EPS matches issuer adjusted EPS of $8.90 for fiscal Q1 2027; GAAP EPS is $6.92. All six frozen normalized historical EPS values match.